Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Faron Pharmaceuticals Company Event

By Inderes
Faron Pharmaceuticals

Regulatory Press Release (6/4/2024): Faron commences a share offering 

More information regarding the public offering: https://www.faron.com/landing-page


Faron Pharmaceuticals is a clinical-stage biopharmaceutical company based in Finland and the United States, with a focus on developing bexmarilimab, a first-in-class, humanized antibody that binds the Clever-1 target on myeloid cells and macrophages.

Clever-1 is an immunosuppressive receptor that promotes tumor growth and metastases when expressed on macrophages. Bexmarilimab primes the tumor microenvironment for optimal antitumor immune responses, in both hematological malignancies and solid tumors.

Stay up to date
Investor events

Recent videos

Rapala H2'25: North American sales a highlight of the end of the year
12.03.2026 klo 17.25 Rapala VMC
Columbus – Presentation of Annual Report 2025
12.03.2026 klo 14.00 Columbus
Tokmanni Q4’25: Dollarstore’s turnaround is stalling
12.03.2026 klo 13.02 Tokmanni Group
Multitude, Webcast, Q4'25
12.03.2026 klo 11.00 Multitude
Rapala VMC Oyj, Audiocast, Q4'25
12.03.2026 klo 11.00 Rapala VMC
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.